Sir Colin Dollery

Sir Colin Dollery graduated from Birmingham University with honours degrees in physiology and in medicine.  He spent almost all his academic career at the Royal Postgraduate Medical School at Hammersmith Hospital and established one of the world-leading departments of clinical pharmacology.   His clinical interest was particularly in the treatment of hypertension both in early phase studies and in the large scale clinical trials conducted by the MRC.  Later in his career he was successively Chairman of the Department of Medicine and Dean of the Medical School.   He had a prominent national and international role in clinical pharmacology and pharmacology and was the first (and so far the only) clinical pharmacologist to become President of the International Union of Pharmacology.   He was the managing Editor of the two volume reference book, “Therapeutic Drugs”.  He is still a member of the receptor nomenclature committee of IUPHAR (NC-IUPHAR).   He served on many public committees including the UK Committee on Safety of Medicines, Medical Sub-Committee of the University Grants Committee (Chairman) and the Physiological Systems Board (Chairman) of the Medical Research Council.

Sir Colin has been a senior consultant to Research and Development in GlaxoSmithKline, and before that in SmithKline Beecham, for 12 years.  He is particularly concerned with the discovery-development interface when new drugs transfer from the laboratory to early studies in man.  In GlaxoSmithKline he is an adviser to Dr Moncef Slaoui, the Chairman of Research and Development, he serves on the committees that review all protocols for human research, the Global Safety Board that reviews all issues related to safety, including approval for first administration of a new drug to man.  He was co-Chairman of the ABPI/BIA Working Party on the Tegenero 1412 episode at Parexel, Northwick Park.

Recent publications

1. C.T. Dollery  (main author of final text)   Safer Medicines,  Academy of Medical Sciences 2005.       
2. C.T. Dollery.  Clinical Pharmacology the first 75 years and a view of the future. British Journal of Clinical Pharmacology 61(6):650-665, 2006
3. C.T. Dollery (Co-Chairman).   Early Stage Clinical Trial Taskforce, Joint ABPI/BIA Report.  2006. 
4. C.T. Dollery (Co-Chairman).   Systems Biology: a vision for engineering and medicine.  Academy of Medical Sciences and Royal Academy of Engineering. 2007.
5. C.T. Dollery.  Beyond Genomics.  Clin Pharm & Ther 82(4):366-369, 2007.
6. C.T Dollery.  Clinical Pharmacology in the Molecular Era, Clin Pharm & Ther 83: 220-225, 2008
7. C.T Dollery.  The Scientific Contribution of Clinical Pharmacology. European Journal of Clinical Pharmacology 64: 99-106, 2008